Skip to main content
Figure 1 | BMC Pulmonary Medicine

Figure 1

From: Subcutaneous implant with etonogestrel (Implanon®) for catamenial exacerbations in a patient with cystic fibrosis: a case report

Figure 1

Respiratory function and intravenous-antibiotic use before and after insertion of first and seconf subcutaneous implant with etonogestrel (Implanon®). ⬇: intravenous antibic; FVC: forced vital capacity; FEV1: forced expired volumen in first second; (1): trimethoprim-sulfamethoxazole; (2) trimethoprim-sulfamethoxazole and linezolid; (3): linezolid; (4): trimethoprim-sulfamthoxazole and ceftazidimel; (5): Imipenem.

Back to article page